Konruns Pharma seeks 2015 listing in Hong Kong
Beijing Konruns Pharmaceuticals Co, a maker of cancer drugs, is planning an IPO in Hong Kong, with the company filing an A-1 on Tuesday. Credit Suisse and Goldman Sachs will jointly sponsor the trade.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: